近期论文

查看导师最新文章 （温馨提示：请注意重名现象，建议点开原文通过作者单位确认）

Annibali, D., Whitfield, JR., Favuzzi, E., Jauset, T., Serrano, E., Cuartas, I., Redondo-Campos, S., Folch, G., Gonzàlez-Juncà, A., Sodir, NM., Massá-Vallás, D., Beaulieu, M-E., Swigart, LB., McGee, MM., Somma, MP., Nasi, S., Seoane, J., Evan, GI. and Soucek, L. (2014). Myc inhibition is effective against glioma and reveals a role for Myc in proficient mitosis. Nature Comm. in the press. Wilson, CH., Gamper,I., Perfetto,A., Auw, J., Littlewood,TD. and Evan, GI. (2014).The kinetics of ER fusion protein activation in vivo. Oncogene, in the press. Shchors, K., Persson, A. I., Rostker, F., Tihan, T., Lyubynska, N., Li, N., Swigart, L. B., Berger, M. S., Hanahan, D., Weiss, W. A., and Evan, G. I. (2013). Using a preclinical mouse model of high-grade astrocytoma to optimize p53 restoration therapy. Proc Natl Acad Sci U S A. Soucek, L., Whitfield, J. R., Sodir, N. M., Masso-Valles, D., Serrano, E., Karnezis, A. N., Swigart, L. B., and Evan, G. I. (2013). Inhibition of Myc family proteins eradicates KRas-driven lung cancer in mice. Genes Dev 27, 504-513. Littlewood, TD, Kreuzaler, P and Evan, GI. (2012). All things to all people. Cell 151, 11-13. Garcia, D., Warr, M.R., Martins, C.P., Brown Swigart, L., Passegue, E., and Evan, G.I. (2011). Validation of MdmX as a therapeutic target for reactivating p53 in tumors. Genes Dev 25, 1746-1757. Sodir, N.M., Swigart, L.B., Karnezis, A.N., Hanahan, D., Evan, G.I., and Soucek, L. (2011). Endogenous Myc maintains the tumor microenvironment. Genes Dev 25, 907-916. Junttila, M.R., Karnezis, A.N., Garcia, D., Madriles, F., Kortlever, R.M., Rostker, F., Brown Swigart, L., Pham, D.M., Seo, Y., Evan, G.I., et al. (2010). Selective activation of p53-mediated tumour suppression in high-grade tumours. Nature 468, 567-571. Finch, A.J., Soucek, L., Junttila, M.R., Swigart, L.B., and Evan, G.I. (2009). Acute overexpression of Myc in intestinal epithelium recapitulates some but not all the changes elicited by Wnt/beta-catenin pathway activation. Mol Cell Biol 29, 5306-5315. Murphy, D.J., Junttila, M.R., Pouyet, L., Karnezis, A., Shchors, K., Bui, D.A., Brown-Swigart, L., Johnson, L., and Evan, G.I. (2008). Distinct thresholds govern Myc's biological output in vivo. Cancer Cell 14, 447-457. Soucek, L., Whitfield, J., Martins, C.P., Finch, A.J., Murphy, D.J., Sodir, N.M., Karnezis, A.N., Swigart, L.B., Nasi, S., and Evan, G.I. (2008). Modelling Myc inhibition as a cancer therapy. Nature 455, 679-683.